Subscribe
VEGF Inhibitor vs Vitrectomy for Diabetic Retinopathy, FFR-Based PCI, USPSTF Guideline on HBV Screening, and more

JAMA Editor’s Summary

VEGF Inhibitor vs Vitrectomy for Diabetic Retinopathy, FFR-Based PCI, USPSTF Guideline on HBV Screening, and more

Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the
December 15, 2020
ADVERTISEMENT
TransferWise

VEGF Inhibitor vs Vitrectomy for Diabetic Retinopathy, FFR-Based PCI, USPSTF Guideline on HBV Screening, and more

Editor’s Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the December 15, 2020 issue

ADVERTISEMENT
TransferWise

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Proudly supported by:

cover
Hera Diagnostics is eradicating cervical cancer in developing communities Teo Tijerina is the CEO of Hera Medical Devices, a cancer diagnostics startup currently focusing on bringing a cervical cancer screening tool to market.